Home / News / India News / Article /
Johnson and Johnson applies for emergency use of single-dose vaccine
Updated On: 07 August, 2021 07:40 AM IST | New Delhi | Agencies
Johnson & Johnson says it will supply the vaccine through a collaboration with Biological E. Limited, the Indian pharma company based in Hyderabad
People queue up for vaccination at a temporary camp set up in a remote village at Morigaon district in Guwahati, on Friday. Pics/AFP
Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization (EUA) of its single-dose vaccine against novel Coronavirus in India. The company, in a statement, said that it will bring the vaccine through a collaboration with Hyderabad-based Biological E. Limited.
“Biological E will be an important part of our global supply chain network, helping to supply our Covid-19 vaccine through the extensive collaborations and partnerships we have with governments, health authorities and organisations such as Gavi and the COVAX Facility,” it added.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT